Skip to main content

FDA panel unanimously recommends J&J Covid booster shots to adults who already got the first dose

By CNBC  
   October 15, 2021

An influential FDA advisory committee on Friday said the agency should authorize boosters of Johnson & Johnson's single-shot COVID-19 vaccine to the more than 15 million Americans who have already received the initial dose.

Full story


Get the latest on healthcare leadership in your inbox.